Company news
Nexsen Limited news in 2026
Nexsen Limited's news releases, calls and decks from 2026, newest first.
Co Secretary Appoint/Resign and Change of Registered Address
November 2, 2026
ISO 13485 Certification brings StrepSure closer to market
November 1, 2026
ISO 13485 Certification brings StrepSure closer to market
November 1, 2026
Quarterly Report - Q1 FY27
October 27, 2026
Quarterly Report - Q1 FY27
October 27, 2026
Notice of AGM and Meeting Materials
October 7, 2026
Professor Shekhar Kumta appointed Executive Director
September 30, 2026
Reinstatement to Quotation
September 24, 2026
Proposed FlashDx joint venture builds on CE-marked GBS test
September 24, 2026
Suspension from Quotation
September 23, 2026
Clear pathway defined to optimise StrepSure
September 23, 2026
Trading Halt
September 21, 2026
Director Interest Notices re Performance Rights
September 10, 2026
Notification regarding unquoted securities - NXN
September 10, 2026
Notification regarding unquoted securities - NXN
September 10, 2026
Annual Report - FY 2026
August 30, 2026
Corporate Governance Statement and Appendix 4G
August 30, 2026
Quarterly Report - Q4 FY26
July 28, 2026
$1.5m non-dilutive ARC funding for manufacturing
June 24, 2026
Nexsen secures first hospital partner in Asia
May 12, 2026
Nexsen and Universiti Malaya launch joint facility
May 3, 2026
Quarterly Report - Q3 FY26
April 27, 2026
QMS milestone achieved
April 6, 2026
HK$6 million grant awarded to advance Asia-Pacific execution
March 30, 2026
Nexsen accelerates global rollout for StrepSure
March 25, 2026
FDA feedback derisks US approval pathway for StrepSure
March 22, 2026
Half Yearly Report and Accounts
February 26, 2026
Quarterly Report - Q2 FY26
January 29, 2026
$500k govt grant expands GBS project to neonates
January 26, 2026